The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women of reproductive age. Obesity is frequently present in these patients and plays a key role in the pathogenesis of both the endocrine and metabolic abnormalities of the syndrome, particularly infertility, hyperandrogenism an...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Pensoft Publishers
2018-12-01
|
| Cyfres: | Folia Medica |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.degruyter.com/view/j/folmed.2018.60.issue-4/folmed-2018-0036/folmed-2018-0036.xml?format=INT |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|